SCHEMBL4928965

SCHEMBL4928965

Nc1sc(CCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)nc1-c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.62
DRD2 P14416 8/20 0.56
DRD3 P35462 7/20 0.56
ADRA1A P35348 6/20 0.56
CACNA1G O43497 2/20 0.53
HTR1A P08908 4/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
MAPT P10636 1/20 0.52
TSHR P16473 1/20 0.52
NFKB1 P19838 1/20 0.52
MAPK1 P28482 1/20 0.52
CYP2C19 P33261 1/20 0.52
THPO P40225 1/20 0.52
MTOR P42345 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4609182 0.80 SIGMAR1 (0.62) SIGMAR1DRD2DRD3ADRA1AHTR1A
SCHEMBL4930259 0.78 SIGMAR1 (0.62) SIGMAR1DRD2DRD3ADRA1ACACNA1G
SCHEMBL9378627 0.78 SIGMAR1 (1.00) SIGMAR1DRD2DRD3ADRA1AHTR1A
SCHEMBL5181068 0.75 SIGMAR1 (0.61) SIGMAR1DRD2DRD3ADRA1AHTR1A
SCHEMBL11465528 0.75 SIGMAR1 (0.76) SIGMAR1DRD2DRD3ADRA1AHTR1A
Hydrochloric Acid SCHEMBL4925988 0.75 SIGMAR1 (0.60) SIGMAR1DRD2DRD3ADRA1AHTR1A
SCHEMBL4927353 0.74 SIGMAR1 (0.62) SIGMAR1DRD2DRD3ADRA1AHTR1A
SCHEMBL9520731 0.74 HTR2C (0.74) SIGMAR1DRD2DRD3ADRA1AHTR1A
SCHEMBL3209307 0.74 SIGMAR1 (0.71) SIGMAR1DRD2DRD3ADRA1AHTR1A
Hydrochloric Acid SCHEMBL4929043 0.74 SIGMAR1 (0.61) SIGMAR1DRD2DRD3ADRA1AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432269-B2 Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents BIOPROJET (FR) 2008-10-07 US disclosed
US-20080167320-A1 NOVEL ARYLPIPERAZINE DERIVATIVES CAPET MARC 2008-07-10 US disclosed
US-20060089364-A1 Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents BIOPROJET (FR) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167320-A1 NOVEL ARYLPIPERAZINE DERIVATIVES DRD2, HTR2C, DRD3 SIGMAR1 134/4885DRD2 1/4885DRD3 3/4885
US-20060089364-A1 Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents CYP4Z1, CYP3A5, CYP1A2 SIGMAR1 911/4885DRD2 1280/4885DRD3 1872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.